Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
about
Resveratrol and clinical trials: the crossroad from in vitro studies to human evidenceHerbal medicines and nonalcoholic fatty liver diseaseAn Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Effects of resveratrol in experimental and clinical non-alcoholic fatty liver diseaseHerbal adaptogens combined with protein fractions from bovine colostrum and hen egg yolk reduce liver TNF-α expression and protein carbonylation in Western diet feeding in ratsEffects of resveratrol and other polyphenols in hepatic steatosis.Risperidone-Induced Renal Damage and Metabolic Side Effects: The Protective Effect of ResveratrolResveratrol ameliorates diet-induced dysregulation of lipid metabolism in zebrafish (Danio rerio).Fatty acid synthase methylation levels in adipose tissue: effects of an obesogenic diet and phenol compounds.Resveratrol in metabolic health: an overview of the current evidence and perspectives.Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.Resveratrol and SRT1720 Elicit Differential Effects in Metabolic Organs and Modulate Systemic Parameters Independently of Skeletal Muscle Peroxisome Proliferator-activated Receptor γ Co-activator 1α (PGC-1α)Pepsin Egg White Hydrolysate Ameliorates Obesity-Related Oxidative Stress, Inflammation and Steatosis in Zucker Fatty Rats.The Combination of Resveratrol and Quercetin Attenuates Metabolic Syndrome in Rats by Modifying the Serum Fatty Acid Composition and by Upregulating SIRT 1 and SIRT 2 Expression in White Adipose Tissue.Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expressionHigh-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.Novel insights of dietary polyphenols and obesityThe role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liver.Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.Resveratrol: anti-obesity mechanisms of action.Functional foods as potential therapeutic options for metabolic syndrome.Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms.Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.Effect of dietary resveratrol on the metabolic profile of nutrients in obese OLETF rats.The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects.Potential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats.Pterostilbene improves glycaemic control in rats fed an obesogenic diet: involvement of skeletal muscle and liver.Antiobesity effects of resveratrol: which tissues are involved?Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells.Involvement of miR-539-5p in the inhibition of de novo lipogenesis induced by resveratrol in white adipose tissue.Resveratrol increases CD68⁺ Kupffer cells colocalized with adipose differentiation-related protein and ameliorates high-fat-diet-induced fatty liver in mice.Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption.Comparison of dietary polyphenols for protection against molecular mechanisms underlying nonalcoholic fatty liver disease in a cell model of steatosis.Protective effect of grape seed and skin extract against high-fat diet-induced liver steatosis and zinc depletion in rat.Pterostilbene-induced changes in gut microbiota composition in relation to obesity.Resveratrol preserves mitochondrial function, stimulates mitochondrial biogenesis, and attenuates oxidative stress in regulatory T cells of mice fed a high-fat diet.
P2860
Q24618313-DD8E3503-2F68-431A-B77C-16EBA8A199DBQ26738524-5818498E-B21D-4241-83C5-8C95D28E7B64Q26800907-4D5C2B78-F437-446E-80D3-43751338E364Q30412771-AA8D6DED-5A11-4FFB-9532-39DFDDEC05FCQ33563877-7380F3F1-03B3-43B2-B434-584A55529E6EQ33597943-438869E0-DE2D-45AA-ABFE-D241635EAB63Q33780166-00EAB94E-C5E2-4843-B218-A63D69777918Q33863719-3B0D3D16-403D-4CD0-AF6A-4FEADA75450AQ33884312-E9B60B9C-3C39-4A16-B18A-15D7AAC82485Q34212884-35E7FBCD-6205-4CBB-BD8C-CA216A3C2EC8Q34357570-D7552097-1945-4F49-942E-B433F513169BQ34412650-C94F3588-D7E1-4F17-A0BC-4088F4F08934Q35783084-BBD265E8-A370-4D0C-A5DB-CF8FC8911F4CQ35960663-B29F522F-B9F0-4B44-BA3B-A5B4702197ABQ36279200-38CE007E-9163-4E5A-A9F8-073DF89098F7Q36470320-EA088CFE-3E98-4567-A7F1-EE4D4A3364F0Q36656592-D9AC5ADC-4A97-44F4-9DEC-E4BC78645F76Q36720635-C0E31ACD-544A-4D18-9EBA-0B5E9937BB97Q37588979-C066F812-D1B4-4D24-B5F6-5D62BAC70315Q38113967-38DCCEFB-2CB6-40DC-8E8D-7041FDA8E16FQ38168505-ABAFBC40-0254-4EF1-AB10-9D985107B0C4Q38269066-E9FC2B00-646E-4819-AAAC-57FDC5669D62Q38582214-9B532BB1-C216-4787-A2EA-37678AB5477EQ38599131-7957D370-2C1E-4153-9502-75D527754A43Q38642318-8BFDA370-C464-41A7-93F0-524E4EDFF192Q38825737-254983F1-962D-41EA-A4CF-3A052F6DDF2DQ39884153-E999E569-2225-4643-B7B1-998784407C92Q40669013-9DD89A23-FBA3-453C-947E-8A818BF6647AQ40824062-DCF227E6-118F-4BEE-9BC4-5827F10B9BD8Q40873779-A03E3FE1-5A72-4E9E-8F19-EACEB71EDDD4Q40914600-F2ECDDF6-5593-41C2-97E5-391EBC164D96Q42006709-EFC19E12-9C65-4BEC-9EA1-5BCC03493CC2Q42519219-5E386661-2CDE-4433-A64C-D9381E6E1FBDQ42813148-D7EA999D-B78F-4513-A130-310581FC2907Q45872967-6173B982-F59B-4D5C-836B-B12318CC8D2CQ46317478-7EB245AF-5922-4607-9D49-33D6EFBA7D8CQ46401825-D32FCC49-2D2B-4FFB-AD85-F3C6967D4DACQ46411016-7082A8A2-FBAC-43E0-9A98-5387F75636EEQ46523185-10E7FE3B-FB49-4045-ACDE-843EC5F0F561Q46847639-FB641385-514E-4433-8AA5-5E77AB9045E6
P2860
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Resveratrol attenuates steatos ...... and reducing oxidative stress.
@en
Resveratrol attenuates steatos ...... and reducing oxidative stress.
@nl
type
label
Resveratrol attenuates steatos ...... and reducing oxidative stress.
@en
Resveratrol attenuates steatos ...... and reducing oxidative stress.
@nl
prefLabel
Resveratrol attenuates steatos ...... and reducing oxidative stress.
@en
Resveratrol attenuates steatos ...... and reducing oxidative stress.
@nl
P2093
P2860
P50
P1476
Resveratrol attenuates steatos ...... and reducing oxidative stress
@en
P2093
A Fernández-Quintela
S Gómez-Zorita
P2860
P304
P356
10.1017/S0007114511002753
P50
P577
2011-06-28T00:00:00Z